The Correlation Between Liquid Biopsy and HER2 Status in Breast Cancer

Dr Parsons on the Correlation Between Liquid Biopsy and HER2 Status in Breast Cancer

Heather A. Parsons, MD, MPH, medical oncologist, Dana-Farber Cancer Institute, assistant professor, medicine, Harvard Medical School, discusses the correlation between liquid biopsy and HER2 status in breast cancer, according to data from a novel epigenomic platform.

Videos

Heather A. Parsons, MD, MPH, discusses the correlation between liquid biopsy and HER2 status in breast cancer, according to data from a novel epigenomic platform.


Heather A. Parsons, MD, MPH

Articles

Dr Parsons on the Correlation Between Liquid Biopsy and HER2 Status in Breast Cancer